769 related articles for article (PubMed ID: 31805015)
1. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
2. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
[TBL] [Abstract][Full Text] [Related]
3. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
Fuchs A; Samovski D; Smith GI; Cifarelli V; Farabi SS; Yoshino J; Pietka T; Chang SW; Ghosh S; Myckatyn TM; Klein S
Gastroenterology; 2021 Sep; 161(3):968-981.e12. PubMed ID: 34004161
[TBL] [Abstract][Full Text] [Related]
4. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
[TBL] [Abstract][Full Text] [Related]
5. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
6. Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
Green CJ; Marjot T; Walsby-Tickle J; Charlton C; Cornfield T; Westcott F; Pinnick KE; Moolla A; Hazlehurst JM; McCullagh J; Tomlinson JW; Hodson L
Eur J Endocrinol; 2022 Feb; 186(3):367-377. PubMed ID: 35038311
[TBL] [Abstract][Full Text] [Related]
7. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
[TBL] [Abstract][Full Text] [Related]
8. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
Beals JW; Smith GI; Shankaran M; Fuchs A; Schweitzer GG; Yoshino J; Field T; Matthews M; Nyangau E; Morozov D; Mittendorfer B; Hellerstein MK; Klein S
Hepatology; 2021 Sep; 74(3):1287-1299. PubMed ID: 33743554
[TBL] [Abstract][Full Text] [Related]
9. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
Fabbrini E; deHaseth D; Deivanayagam S; Mohammed BS; Vitola BE; Klein S
Obesity (Silver Spring); 2009 Jan; 17(1):25-9. PubMed ID: 18948971
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
[TBL] [Abstract][Full Text] [Related]
11. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease.
Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ
Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347
[TBL] [Abstract][Full Text] [Related]
13. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
[TBL] [Abstract][Full Text] [Related]
14. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
[TBL] [Abstract][Full Text] [Related]
16. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Korenblat KM; Fabbrini E; Mohammed BS; Klein S
Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
18. Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver.
Fu X; Fletcher JA; Deja S; Inigo-Vollmer M; Burgess SC; Browning JD
J Clin Invest; 2023 May; 133(9):. PubMed ID: 36928190
[TBL] [Abstract][Full Text] [Related]
19. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
[TBL] [Abstract][Full Text] [Related]
20. MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studies.
Nagarajan SR; Livingstone EJ; Monfeuga T; Lewis LC; Ali SHL; Chandran A; Dearlove DJ; Neville MJ; Chen L; Maroteau C; Ruby MA; Hodson L
Metabolism; 2023 Jul; 144():155563. PubMed ID: 37088121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
